Why Diversity in Clinical Trials Matters for Cystic Fibrosis Research
Post Preview Key Takeaways: Introduction Cystic Fibrosis (CF) is a complex, life-shortening genetic disorder affecting over 70,000 individuals worldwide, particularly impacting the lungs and digestive systems. While significant advancements have been made in medical treatments and management strategies for CF, a substantial gap remains in ensuring that clinical trials reflect the diversity of populations most…